RecruitingNCT07486219

Magnetic Resonance Imaging of the Lung: Oncological Applications


Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment

50 participants

Start Date

Jan 15, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Lung neoplasms are characterized by a complex interaction between tumor cells and a variety of resident and infiltrating host elements, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Nowadays, in the setting of lung cancer, and in particular non-small cell lung cancer (NSCLC), the evaluation of microenvironment characteristics can only be performed by a pathologist and only on histological material. By combining different MRI parameters, it may be possible to create a specific imaging "signature" for the three different immune phenotypes and thus be able to make a distinction based on MRI examination.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Primary NSCLC of the lung (TNM 8th edition T parameter ≥T1c)
  • Biopsy examination of the primary tumor adequate at least for PDL-1 quantification
  • Staging CT scan with uncertain N parameter and definite M parameter.

Exclusion Criteria1

  • Absolute contraindications to magnetic resonance imaging or the administration of gadolinium-based contrast agents

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione IRCCS Policlinico San Matteo

Pavia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07486219


Related Trials